Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
K.C. Toh
Observed name:
Kane Toh
Institution:
National Cancer Centre Singapore
Observed institutions:
National University of Singapore,
National Cancer Centre Singapore,
Cancer Science Institute of Singapore
ORCID:
0000-0001-6882-1110
Observed ORCID:
0000-0001-6882-1110
OpenAlex ID:
A5042405566
Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrence
2026
·
Veerabrahma P. Seshachalam
, Ita N. Sari
, et al.
·
JHEP Reports
·
3
EP12.02-09 Prevalence and Treatment of Advanced NSCLC patients with REarranged During Transfection [RET]-fusion at a South Korean Centre
2023
·
S. Yoon
, K.-P. Kim
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
349P EXPLORE-LC: A multi-site real-world evidence research platform for non-small cell lung cancer in Asia-Pacific
2022
·
K.C. Toh
, X. Zhao
, et al.
·
Annals of Oncology
·
1
PDF
Abstract B006: GSTT2 modulates immune activation and impacts response to BCG immunotherapy in bladder cancer
2024
·
Mugdha Vijay Patwardhan
, Kane Toh
, et al.
·
Clinical Cancer Research
Abstract P29: GSTT2 AND THE RESPONSE TO BCG IMMUNOTHERAPY
2024
·
Mugdha Patwardhan
, Kane Toh
, et al.
·
Cancer Research
EP11.03-38 Comparison of Real-World Outcomes in aNSCLC Patients Receiving 1L Immunotherapy Alone or in Combination with Chemotherapy
2023
·
S.M. Lim
, H.A. Jung
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type